Paloma Partners’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Paloma Partners’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,000	Closed	-$209K	–	978
2023 Q1	$209K	Hold	20,000	–	–	0.01%	621
2022 Q4	$206K	Hold	20,000	–	–	0.01%	705
2022 Q3	$201K	Hold	20,000	–	–	0.01%	732
2022 Q2	$199K	Hold	20,000	–	–	0.01%	880
2022 Q1	$200K	Hold	20,000	–	–	0.01%	1406
2021 Q4	$197K	Buy	+20,000	New	+$198K	﹤0.01%	1615

Paloma Partners's LVAC Position: Q1 2023 in Review

Paloma Partners sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q1 2023, closing a stake of 40,000 shares — an estimated $414K sold.

Paloma Partners first reported a position in LVAC in Q4 2021 and held it in 5 quarters. The position peaked at $411K in Q4 2022. 54 funds tracked by Wall St. Rank hold LVAC as of Q1 2023.

Paloma Partners reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Paloma Partners sold 40,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $414K.
Paloma Partners first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Paloma Partners's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $411K in Q4 2022.
54 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Paloma Partners's 13F filing for Q1 2023, filed 15 May 2023.